MyFinsight
Home
Compare
About
Recent SEC Filings
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
DFTX Cash Flow Sankey Diagram
Sankey diagram visualizing DFTX cash flow for the period
Proceeds from equity
offerings
$805,000K
Proceeds from exercise of
2022 usd financing...
$2,819K
Proceeds from exercise of
options
$860K
Proceeds from exercise of
pre-funded warrants
$5K
Net cash provided by
financing activities
$762,266K
Canceled cashflow
$46,418K
Net
increase/(decrease) in cash and cash...
$392,749K
Canceled cashflow
$369,517K
Payment of equity
offering costs
$46,418K
Maturity of investments
$39,000K
Change in fair value of
2022 usd financing...
$86,231K
Stock-based compensation
$9,639K
Accrued expenses
$6,853K
Change in fair value on
directors' deferred share...
-$5,213K
Other non-cash
adjustments
$216K
Net cash used in
investing activities
-$316,738K
Net cash used in
operating activities
-$52,778K
Effect of exchange rate
changes on cash
-$1K
Canceled cashflow
$39,000K
Canceled cashflow
$108,152K
Purchases of investments
$355,738K
Net loss
-$158,986K
Accretion of discount on
investments, net
$1,364K
Prepaid and other
current assets
$264K
Accounts payable
-$162K
Other noncurrent
assets
$133K
Unrealized foreign
exchange
$11K
Other liabilities,
long-term
$10K
Total other
income/(expense), net
-$83,909K
Loss from operations
-$75,077K
Research And Development
$48,665K
General And
Administrative
$26,412K
Back
Back
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com